Question 1

What is the catalog number for 6,7-dihydro-9H-pyrano[4,3-e][1,2,4]triazolo[1,5-a]pyrimidin-9-one?

Accepted Answer

The catalog number for 6,7-dihydro-9H-pyrano[4,3-e][1,2,4]triazolo[1,5-a]pyrimidin-9-one is sc-357213A.

Question 2

What sizes are available for 6,7-dihydro-9H-pyrano[4,3-e][1,2,4]triazolo[1,5-a]pyrimidin-9-one?

Accepted Answer

6,7-dihydro-9H-pyrano[4,3-e][1,2,4]triazolo[1,5-a]pyrimidin-9-one is available in the following size(s): 1 g.

Question 3

Is 6,7-dihydro-9H-pyrano[4,3-e][1,2,4]triazolo[1,5-a]pyrimidin-9-one in stock?

Accepted Answer

6,7-dihydro-9H-pyrano[4,3-e][1,2,4]triazolo[1,5-a]pyrimidin-9-one is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What documentation should I request if this product is used for a regulated or intellectual-property-sensitive application?

Accepted Answer

If the product is subject to intellectual property protections, we’ll advise on any MTA or usage restrictions before shipping. Let us know your intended end use so we can confirm what’s required upfront.

Question 5

Is this antibody conjugated?

Accepted Answer

Conjugation status, such as unconjugated, HRP, FITC, or biotin, is specified in the product name and confirmed on the datasheet.

Question 6

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

6,7-dihydro-9H-pyrano[4,3-e][1,2,4]triazolo[1,5-a]pyrimidin-9-one

Product Specifications

Frequently Asked Questions

Explore Other Products

Napsin-A (NAPSA/1238), CF405S conjugate, 0.1mg/mL

Cathepsin D (Tumor Marker) (CTSD/3083), CF488A conjugate, 0.1mg/mL

AKT1 (Prognostic Marker for Neuroendocrine Tumors) (AKT1/2491), 1mg/mL

CD95 (B-R18), CF594 conjugate, 0.1mg/mL

P53 Tumor Suppressor Protein (TP53/1739), CF568 conjugate, 0.1mg/mL

Anti-M-phase inducer phosphatase 2 Cdc25B Antibody Picoband®, PE Conjugate